Axa S.A. grew its position in shares of Ambarella, Inc. (NASDAQ:AMBA – Free Report) by 0.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 542,715 shares of the semiconductor company’s stock after purchasing an additional 1,734 shares during the quarter. Axa S.A. owned approximately 1.37% of Ambarella worth $42,017,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in AMBA. Daiwa Securities Group Inc. lifted its stake in shares of Ambarella by 24.4% in the first quarter. Daiwa Securities Group Inc. now owns 939 shares of the semiconductor company’s stock worth $73,000 after acquiring an additional 184 shares during the period. Belpointe Asset Management LLC acquired a new position in shares of Ambarella in the fourth quarter worth approximately $77,000. Tower Research Capital LLC TRC lifted its stake in shares of Ambarella by 53.8% in the first quarter. Tower Research Capital LLC TRC now owns 1,155 shares of the semiconductor company’s stock worth $89,000 after acquiring an additional 404 shares during the period. Great West Life Assurance Co. Can acquired a new position in shares of Ambarella in the first quarter worth approximately $133,000. Finally, Advisors Asset Management Inc. lifted its stake in shares of Ambarella by 30.0% in the first quarter. Advisors Asset Management Inc. now owns 1,537 shares of the semiconductor company’s stock worth $161,000 after acquiring an additional 355 shares during the period. 79.74% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Ambarella news, CFO Brian C. White sold 3,297 shares of the company’s stock in a transaction on Tuesday, June 20th. The stock was sold at an average price of $84.80, for a total value of $279,585.60. Following the completion of the transaction, the chief financial officer now owns 80,771 shares in the company, valued at approximately $6,849,380.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Ambarella news, VP Christopher Day sold 3,000 shares of the company’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $86.94, for a total value of $260,820.00. Following the completion of the transaction, the vice president now owns 10,831 shares in the company, valued at approximately $941,647.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brian C. White sold 3,297 shares of the company’s stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $84.80, for a total value of $279,585.60. Following the completion of the transaction, the chief financial officer now owns 80,771 shares of the company’s stock, valued at approximately $6,849,380.80. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 20,724 shares of company stock worth $1,747,120. 5.90% of the stock is owned by corporate insiders.
Ambarella Trading Down 0.9 %
Ambarella (NASDAQ:AMBA – Get Free Report) last announced its quarterly earnings results on Tuesday, August 29th. The semiconductor company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.06. Ambarella had a negative return on equity of 14.40% and a negative net margin of 33.72%. The business had revenue of $62.10 million during the quarter, compared to the consensus estimate of $62.02 million. During the same quarter in the prior year, the company posted ($0.51) earnings per share. Ambarella’s revenue was down 23.2% compared to the same quarter last year. On average, analysts predict that Ambarella, Inc. will post -3.46 EPS for the current year.
Analyst Ratings Changes
A number of equities analysts recently commented on AMBA shares. Morgan Stanley cut their price objective on Ambarella from $89.00 to $81.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 30th. Susquehanna dropped their price target on Ambarella from $92.00 to $80.00 and set a “positive” rating on the stock in a research note on Wednesday, August 30th. Needham & Company LLC dropped their price target on Ambarella from $100.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, August 30th. Stifel Nicolaus dropped their price target on Ambarella from $95.00 to $78.00 and set a “buy” rating on the stock in a research note on Wednesday, August 30th. Finally, TD Cowen lowered Ambarella from an “outperform” rating to a “market perform” rating and dropped their price target for the company from $90.00 to $65.00 in a research note on Wednesday, August 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $84.63.
View Our Latest Stock Report on Ambarella
Ambarella Company Profile
Ambarella, Inc develops semiconductor solutions that enable high-definition (HD) and ultra HD compression, image processing, and deep neural network processing worldwide. The company's system-on-a-chip designs integrated HD video processing, image processing, artificial intelligence computer vision algorithms, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption.
Further Reading
- Five stocks we like better than Ambarella
- How to Capture the Benefits of Dividend Increases
- MarketBeat Week in Review – 9/4 – 9/8
- What are stock market earnings reports?
- The Best 5 Small Cap AI Companies to Buy Now
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Miso Robotics Stock: Is an IPO Coming Soon?
Want to see what other hedge funds are holding AMBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambarella, Inc. (NASDAQ:AMBA – Free Report).
Receive News & Ratings for Ambarella Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambarella and related companies with MarketBeat.com's FREE daily email newsletter.